National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Case scenarios
Gavin, 45, is admitted to your hospital for elective surgery on his anterior cruciate ligament (ACL) after rupturing it playing soccer. He is otherwise fit and well, apart from mild hypertension, for which he takes irbesartan with hydrochlorothiazide 150/25 mg daily. Routine blood tests taken at the time of surgery (12 hours ago now) reveal a serum potassium of 3.1 mmol/L (mild hypokalaemia).
Grace, 75, is admitted to hospital with rapid atrial fibrillation (heart rate is 130 bpm), signs of confusion and an infective exacerbation of COPD. She has a history of stage 1 (mild) chronic kidney disease, pulmonary hypertension and subsequent right-sided heart failure secondary to COPD. She takes furosemide 40 mg twice daily, irbesartan 150 mg daily and an indacaterol 110 mcg plus glycopyrronium 50 mcg inhaler, 1 dose daily. A blood test on admission reveals a serum potassium of 3.3 mmol/L (mild hypokalaemia).
Learning ObjectivesAfter reading this article, pharmacists should be able to:
Competency standards (2016) addressed: 1.1, 1.3, 1.4, 1.5, 3.1, 3.2, 3.3, 3.5 Accreditation number: CAP2407AMKW Accreditation expiry: 30/06/2027 |
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
